SRPT
Sarepta Therapeutics, Inc. · Healthcare
President and CEO Douglas S Ingram bought $2.0M of Sarepta Therapeutics, Inc.
Bought$2,000,578
$79.94Price
25,026Shares
+7%Stake
What SRPT did for a copier
- $1,000 copied at Thu, Nov 18 open, $81.78
- $1,106
- S&P 500, same days
- +2.2%
Measured over 30 trading days, to the Jan 3 close.
Douglas S Ingram's record
6 other buys on record. A record shows here once 3 of them have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, Nov 17. Filed Wed, Nov 17, 6:24 PM ET, after the close. Returns use the Nov 18 open and the Jan 3 close. Not investment advice.